{"id":"W2064338630","doi":"10.1182/blood-2014-06-581611","title":"Oral therapy for multiple myeloma: ixazomib arriving soon","year":2014,"lang":"en","type":"letter","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Ixazomib; Multiple myeloma; Medicine; Internal medicine; Oncology; Intensive care medicine; Lenalidomide; Carfilzomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001173073,0.0008485285,0.001082394,0.0007437617,0.001802259,0.002366171,0.0009104593,0.01274507,0.004148107],"category_scores_gemma":[0.004481221,0.0003930516,0.000943226,0.0005735305,0.001164671,0.00256809,0.0007281753,0.01476597,0.004952113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002524068,"about_ca_system_score_gemma":0.001031691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009953589,"about_ca_topic_score_gemma":0.002935273,"domain_scores_codex":[0.9989889,0.0001913214,0.0001034136,0.0001098451,0.00045858,0.0001479177],"domain_scores_gemma":[0.9989801,0.0003837284,0.0001204856,0.00003622837,0.0002036658,0.0002757414],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002370485,0.0002177414,0.00186386,0.000215153,0.00003917965,0.0192365,0.00009525401,0.0001790908,0.001196464,0.003238121,0.9042196,0.06926201],"study_design_scores_gemma":[0.0004853707,0.0006245089,0.002316411,0.0004724187,0.00007827174,0.02737731,0.0002651624,0.0009014334,0.0009159957,0.007412791,0.9591017,0.00004863175],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.002488596,0.01793717,0.0007357139,0.8845254,0.08472575,0.00007037941,0.00006448567,0.0001437355,0.009308831],"genre_scores_gemma":[0.01467028,0.02008024,0.001100289,0.7268326,0.2172518,0.00005287748,0.0001005646,0.0000565503,0.01985482],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01274507,"threshold_uncertainty_score":0.01831347,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05015570316181866,"score_gpt":0.3130272583517268,"score_spread":0.2628715551899082,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}